KUALA LUMPUR: Perodua has succeeded in reducing the waiting time of the Aruz to between 1 month and 1.5 months depending on model from a waiting period of about between 2 months and 2.5 months previously on increased production.
Due to the increase in
production, Perodua estimates that its January to July sales achievement reached 140,900 for all models, which is on par with 140,900 units from the same period last year. The company said it sold 17,989 units of the Aruz between January and July this year.
“In terms of comparison, the months of June, July and August last year saw a ‘tax holiday’ resulting from the elimination of the Goods and Services Tax or GST by the government.”
“Notwithstanding the circumstance, we are fortunate that our performance so far is comparable to the ‘tax holiday’ impact,” Perodua president and chief executive officer, Datuk Zainal Abidin Ahmad said in a statement yesterday.
On the Aruz, Zainal said Perodua was able to further improve on its production processes resulting in better delivery of the SUV.
“We continue to focus on quality and delivery as our customers comes first. We thank you for your continued and strong support which has led to the Aruz being the most popular SUV in Malaysia — this is truly an important milestone for us,” he said.
He added that Perodua is keeping to its sales target of 235,000 units by year-end which is an increase of 3.4 percent from 227,234 units sold in 2018.
On July 17, Perodua announced that it will increase its sales target to 235,000 units for 2019, an increase of 4,000 from its 231,000 target announced in January. The increase in sales target was to meet with strong demand for all its
current models.
The total production target for 2019 has been revised to 249,000 units, up 2.9 percent from the
previous target of 242,000 units.
Both manufacturing plants are operating at 97 percent capacity, which Perodua notes as stabilised at the optimum level of operating condition. This has increased from last year’s figures of 96.2 percent for PMSB and 94.6 percent for PGMSB, while defects per unit (DPU) at both plants have recorded steady declines.
